Join to view full profile
707 E Main StRadiologic Associates, PcMiddletown, NY 10940
Phone+1 845-333-1258
Fax+1 845-343-0617
Dr. Greco is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Radiology-Diagnostic, 1994 - 1998
Westchester Medical CenterInternship, Internal Medicine, 1993 - 1994
New York Medical CollegeClass of 1993
Certifications & Licensure
NY State Medical License 1996 - 2028
FL State Medical License 2006 - 2027
VA State Medical License 2007 - 2026
NJ State Medical License 1999 - 2025
MD State Medical License 2022 - 2024
PA State Medical License 2016 - 2024
CT State Medical License 2001 - 2012
American Board of Radiology Diagnostic Radiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MedInformatix, MedInformatix, 2012-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification MedInformatix, MedInformatix, 2012-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification MedInformatix Complete EHR, MedInformatix, 2012-2014, 2016-2017
Publications & Presentations
PubMed
- 5 citationsGemtuzumab ozogamicin as maintenance therapy after autologous stem cell transplantation in elderly patients with acute myeloid leukaemia.Nicola Cascavilla, Giovanni D'Arena, Michele Mario Greco, Lorella Melillo, Emanuela Merla
British Journal of Haematology. 2008-09-01 - 14 citationsBortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomide.Pellegrino Musto, Antonietta Falcone, Grazia Sanpaolo, Tommasina Guglielmelli, Renato Zambello
Leukemia Research. 2006-03-01 - 17 citationsShort progression-free survival in myeloma patients receiving rituximab as maintenance therapy after autologous transplantation.Pellegrino Musto, Angelo Michele Carella, Michele Mario Greco, Antonietta Falcone, Grazia Sanpaolo
British Journal of Haematology. 2003-11-01
Press Mentions
Veru Inc. (VERU) Q4 2020 Earnings Call TranscriptDecember 9th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
